Concentrations of ceftazidime, tobramycin and ampicillin in the cerebrospinal fluid of newborn infants

Eur J Pediatr. 1989 Jun;148(7):679-81. doi: 10.1007/BF00441533.

Abstract

Thirty-five neonates with suspected septicaemia were randomized to treatment with tobramycin or ceftazidime, both in combination with ampicillin. Concentrations of antibiotics in the CSF were measured 1 h after the third, fourth or fifth injection. In 13 of 17 neonates tobramycin CSF concentrations were below 0.5 mg/l. Ceftazidime CSF concentrations ranged from 2.5 to 17 mg/l, which should be sufficient for treatment of infections with group B streptococci and most aerobic gram-negative bacilli but not all strains of Staphylococcus aureus. Ampicillin CSF concentrations ranged from 1 to 80 mg/l, which should be sufficient for treatment of meningitis caused by enterococci and Listeria monocytogenes, the most important neonatal pathogens not covered by ceftazidime.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Ampicillin / cerebrospinal fluid*
  • Ceftazidime / cerebrospinal fluid*
  • Female
  • Humans
  • Infant, Newborn / cerebrospinal fluid*
  • Male
  • Meningitis / drug therapy
  • Sepsis / drug therapy
  • Tobramycin / cerebrospinal fluid*

Substances

  • Ampicillin
  • Ceftazidime
  • Tobramycin